Alnylam Pharmaceuticals Inc (ALNY)
246.88
-1.91
(-0.77%)
USD |
NASDAQ |
Nov 21, 16:00
249.68
+2.80
(+1.13%)
After-Hours: 20:00
Alnylam Pharmaceuticals Market Cap: 31.84B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 32.09B |
| November 19, 2024 | 30.22B |
| November 18, 2024 | 29.96B |
| November 15, 2024 | 30.38B |
| November 14, 2024 | 33.27B |
| November 13, 2024 | 34.13B |
| November 12, 2024 | 34.69B |
| November 11, 2024 | 36.09B |
| November 08, 2024 | 35.78B |
| November 07, 2024 | 35.11B |
| November 06, 2024 | 35.21B |
| November 05, 2024 | 34.22B |
| November 04, 2024 | 34.82B |
| November 01, 2024 | 35.33B |
| October 31, 2024 | 34.39B |
| October 30, 2024 | 36.31B |
| October 29, 2024 | 36.72B |
| October 28, 2024 | 37.01B |
| October 25, 2024 | 36.74B |
| October 24, 2024 | 37.84B |
| October 23, 2024 | 37.99B |
| October 22, 2024 | 38.20B |
| October 21, 2024 | 37.62B |
| October 18, 2024 | 38.13B |
| October 17, 2024 | 38.23B |
| Date | Value |
|---|---|
| October 16, 2024 | 38.72B |
| October 15, 2024 | 37.02B |
| October 14, 2024 | 36.50B |
| October 11, 2024 | 36.63B |
| October 10, 2024 | 35.90B |
| October 09, 2024 | 34.90B |
| October 08, 2024 | 34.94B |
| October 07, 2024 | 34.37B |
| October 04, 2024 | 34.53B |
| October 03, 2024 | 34.73B |
| October 02, 2024 | 34.99B |
| October 01, 2024 | 35.57B |
| September 30, 2024 | 35.44B |
| September 27, 2024 | 35.29B |
| September 26, 2024 | 35.25B |
| September 25, 2024 | 35.01B |
| September 24, 2024 | 34.79B |
| September 23, 2024 | 34.90B |
| September 20, 2024 | 35.16B |
| September 19, 2024 | 35.48B |
| September 18, 2024 | 35.07B |
| September 17, 2024 | 35.24B |
| September 16, 2024 | 34.71B |
| September 13, 2024 | 34.06B |
| September 12, 2024 | 33.60B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.53B
Minimum
Mar 12 2020
38.72B
Maximum
Oct 16 2024
21.07B
Average
20.12B
Median
Market Cap Benchmarks
| Pfizer Inc | 142.44B |
| BridgeBio Pharma Inc | 4.397B |
| Gilead Sciences Inc | 111.91B |
| Johnson & Johnson | 374.39B |
| Regeneron Pharmaceuticals Inc | 81.80B |
Market Cap Related Metrics
| PS Ratio | 14.94 |
| Price to Book Value | 984.20 |
| Price to Free Cash Flow | 1948.40 |
| Price | 246.88 |
| Earnings Yield | -1.06% |